Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered ... late-stage investigational compounds also delivered by the RESPIMAT ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Ipratropium bromide 20mcg, albuterol 100mcg (equivalent ... Actuate the inhaler toward the ground until an aerosol cloud is visible and then repeat the process three more times.

The decrease in serum potassium is usually transient, not requiring supplementation. Ipratropium bromide, a component of Combivent Inhalation Aerosol and Combivent Respimat, is an anticholinergic and ...

Ipratropium ... efficacy of this compound in asthma and COPD, in comparison with short-acting β 2-agonsists. Table 1 summarizes the main studies comparing ipratropium bromide with salbutamol ...

has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling ...

Distribution of COMBIVENT (ipratropium bromide and albuterol sulfate) Inhalation Aerosol (COMBIVENT MDI ... RESPIMAT inhaler with other late-stage compounds for respiratory patient populations ...

Objectives: To compare the efficacy and tolerability of formoterol (12 or 24µg twice daily) alone with combined ipratropium bromide and fenoterol in the treatment of chronic obstructive pulmonary ...

The damage in the lungs caused by COPD is not reversible, but it is treatable. COMBIVENT Inhalation Aerosol can cause the narrowing of the airways to get worse (paradoxical bronchospasm ...

RIDGEFIELD, Conn., Oct. 7, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new ...